Cerebrospinal fluid decoded to understand tumor evolution
Scientists from the National Center for Genomic Analysis (CNAG) have deciphered cerebrospinal fluid to analyze how brain tumors evolve and understand their resistance to cancer treatments.
TL;DR
- Researchers have decoded cerebrospinal fluid to study brain tumor evolution and treatment resistance.
- This analysis provides high-resolution images of immune cells and their interactions in patients with central nervous system tumors.
- Cerebrospinal fluid is now considered a potent prognostic tool for brain tumors.
- The study analyzed over 70,000 cells from cancer patients and compared them with cells from individuals with neuroinflammatory disorders.
- Pioneering sequencing techniques allowed individual RNA analysis of cerebrospinal fluid cells, revealing gene activation and tumor response.
- The research identified T-cell receptors, which indicate the intensity of the immune response against cancer.
- Complementary analysis included tumor DNA and spatial transcriptomics to map cells within their environment.
- The findings suggest that each tumor type creates a unique microenvironment within the cerebrospinal fluid.
- This research could lead to personalized therapies that leverage the body's natural defenses against cancer.
- The study is currently in its second phase, expanding the analysis to more patients before and after treatment.